Cure8 research brief
The study maps how two ginger preparations differently affect metabolism and the gut microbiome in a mouse model of ulcerative colitis, which could inform more targeted use of ginger-derived treatments if findings are validated in humans.
Researchers studying microbiome–host interactions, clinicians interested in complementary therapies for UC, and patients curious about herbal/ginger-based approaches (as preclinical background).
The study compared dried ginger (DG) and processed ginger (PG) in a mouse model of UC using serum LC–MS metabolomics and 16S rRNA microbiome sequencing.
Both preparations improved UC-related measures in mice; PG appeared to have stronger effects on coagulation/hemostasis and altered steroid-biosynthesis–related metabolites, while DG more strongly affected arachidonic-acid–related metabolism.
The authors report that DG and PG each changed the richness/diversity of the gut microbiota and regulated overlapping but distinct bacterial families and genera. Correlation analysis suggested PG more markedly reshaped connections between host metabolism and the gut microbiota.
The paper frames results as mechanistic data to support more precise application of different ginger-derived medicinal materials for UC.
Results are from a mouse model and multi-omics analyses reported in the article abstract. These findings are mechanistic and exploratory rather than clinical evidence of safety or efficacy in people with UC.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Researchers are exploring plant-derived polysaccharides as potential therapies that might reduce inflammation and protect the intestinal barrier. For people with UC, therapies that reduce pyroptosis and restore...
Gut microbes produce small molecules that interact with the host. This study shows lower levels of certain microbial aromatic carboxaldehydes (I3A and 4HBA) in feces from people with Crohn’s disease, suggesting a...
The study synthesizes many stool metagenomes to find consistent microbial species, functional pathways, and strain-level differences linked to IBD and to distinctions between Crohn’s disease and ulcerative...
